Home Fairfield Alliance for Gene Cancer Therapy names new chief executive

Alliance for Gene Cancer Therapy names new chief executive

SHARE

Alliance for Cancer Gene Therapy, a Stamford-based nonprofit that focuses on

Kevin Honeycutt

funding cancer cell and gene therapy research, has named Kevin Honeycutt as its new president and CEO, effective Dec. 3.

Honeycutt comes to AGCT from the Avon Breast Cancer Crusade, where he served as president and CEO since 2015. Prior to that, he was executive director of the Avon Foundation for Women, a corporate philanthropic division of Avon Products Inc. Earlier in his career, he ran his own consulting firm that specialized in cause marketing communications and fundraising strategies for nonprofits.

Honeycutt replaces John E. Walter, who left AGCT last December to take on the role of CEO for the Foundation for Prader Willi Research.

Print Friendly, PDF & Email
Previous articleKate Wark: Finding the right event venue
Next articleWhite Plains Hospital reports that healthy communities are an economic engine
Phil Hall's writing for Westfair Communications has earned multiple awards from the Connecticut Press Club and the Connecticut Society of Professional Journalists. He is a former United Nations-based reporter for Fairchild Broadcast News and the author of 10 books (including the 2020 release "Moby Dick: The Radio Play" and the upcoming "Jesus Christ Movie Star," both published by BearManor Media). He is also the host of the SoundCloud podcast "The Online Movie Show," co-host of the WAPJ-FM talk show "Nutmeg Chatter" and a writer with credits in The New York Times, New York Daily News, Hartford Courant, Wired, The Hill's Congress Blog, Profit Confidential, The MReport and StockNews.com. Outside of journalism, he is also a horror movie actor - usually playing the creepy villain who gets badly killed at the end of each film.

LEAVE A REPLY

Please enter your comment!
Please enter your name here